01 · Appearance
Visual inspection of the sample as part of the laboratory quality-control assessment.
We believe “tested” should mean more than a purity number.
Every Pepreva batch is independently evaluated through an 8-point Full QC Panel by a third-party laboratory, creating a much more complete analytical picture of the compound than HPLC purity alone.

Because 99% purity is one result.
We wanted the bigger picture.
Eight analyses look beyond a single purity number — examining identity, quantity and key contaminants in the tested sample.
Visual inspection of the sample as part of the laboratory quality-control assessment.
HPLC analysis measures target peptide purity and identifies peptide-related impurities.
Confirms molecular identity using LC-MS analysis.
Analytical testing confirms the identity of the compound being tested.
ICP-MS analysis screens for potentially harmful elemental contaminants.
PCR-based microbial testing evaluates the sample for detectable microbial contamination.
USP <85> testing evaluates bacterial endotoxin levels.
Immunoassay screening specifically checks the sample for fentanyl.
Together, these eight analyses examine what the compound is, how pure it is, how much is actually present, and whether important contaminants are detected.
| Test | Result | Status |
|---|---|---|
| Identity (HPLC) | Confirmed | PASS |
| Fentanyl Screen | Not Detected | PASS |
| Appearance | Good | PASS |
| Sterility (PCR) | No Growth | PASS |
| Endotoxin (USP <85>) | 0.15 EU/mL | REPORTED |
| Heavy Metals (ICP-MS) | Within limits | PASS |
| pH | 7 | PASS |
| Benzyl Alcohol | 0.98% | PASS |
Every released Pepreva batch is backed by its laboratory documentation, and every vial carries a batch number and QR code linking researchers to the corresponding Certificate of Analysis.
Check Lab ResultsThird-party laboratory evaluation.
Documentation tied to the tested batch.
COA access for released batches.
Not for human or veterinary use.